Article

Blood transcriptomics reveal persistent SARS-CoV-2 RNA and candidate biomarkers in Long COVID patients

2024-01-17

Abstract excerpt

With an estimated 65 million individuals suffering from Long COVID, validated therapeutic strategies as well as non-invasive biomarkers are direly needed to guide clinical management. We used blood digital transcriptomics in search of viral persistence and Long COVID diagnostic biomarkers in a real-world, general practice-based setting with a long clinical follow-up. We demonstrate systemic SARS-CoV-2 persistence...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 77f2f042-ac34-5e83-b0b5-07c0df38d54a
DOI: 10.1101/2024.01.14.24301293

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Blood transcriptomics reveal persistent SARS-CoV-2 RNA and candidate biomarkers in Long COVID patientsDOI 10.1101/2024.01.14.24301293Read

Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 conditionSemantic proximity Read

SARS-CoV-2 Mpro protease as a biomarker and therapeutic target in Long COVID: a real-world prospective cohort studySemantic proximity Read

Characterisation of the blood RNA host response underpinning severity in COVID-19 patientsSemantic proximity Read

Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID.Semantic proximity Read

High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized IndividualsSemantic proximity Read

Characterisation of the blood RNA host response underpinning severity in COVID-19 patientsSemantic proximity Read

Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of diseaseSemantic proximity Read

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Semantic proximity Read

Molecular and Immunological Signatures of Long COVID: Implications for Diagnosis and Personalized Treatment StrategiesSemantic proximity Read

Omics-Based Computational Approaches for Biomarker Identification, Prediction, and Treatment of Long COVIDSemantic proximity Read

Advances in Understanding Long COVID: Pathophysiological Mechanisms and the Role of Omics Technologies in Biomarker IdentificationSemantic proximity Read

A blood-based mRNA signature distinguishes people with Long COVID from recovered individualsSemantic proximity Read